3 Things to Look for in a CDMO That Actually Executes Well

Most CDMOs can present strong capabilities.

They have the right equipment.

They have experienced teams.

They have case studies that show success.

On paper, many partners look similar.

The difference becomes clear during execution.

From development through manufacturing and sterile fill finish, the programs that move forward smoothly are not defined by capability alone. They are defined by how work actually gets done when complexity shows up.

If you are evaluating a CDMO, here are three things that matter more than most teams realize.

1. How They Handle Uncertainty, Not Just What They Promise

Early conversations are often polished.

Timelines look achievable.

Processes seem scalable.

Fill-finish plans appear straightforward.

But development programs evolve quickly. Data changes. Assumptions get tested. New constraints appear.

The real question is not what a CDMO promises at the start. It is how they respond when things do not go exactly as planned.

Do they surface risks early?

Do they provide context with their data?

Do they adjust proactively or react later?

Strong partners are transparent about uncertainty. They help you navigate it, not avoid it.

This is one of the clearest indicators of how execution will feel six months into the program.

2. How Early Their SMEs Are Involved

Subject matter experts are critical to program success. The timing of their involvement matters just as much as their expertise.

In some partnerships, SMEs are brought in only when issues appear. By then, options may already be limited.

In stronger programs, SMEs are involved early across development, manufacturing, and sterile fill finish.

They help:

• Evaluate readiness before tech transfer

• Identify scale-up risks

• Align analytical and process expectations

• Flag fill-finish considerations before they become constraints

Early SME involvement reduces rework and improves decision quality.

It also creates alignment across teams before execution pressure increases.

3. How They Connect Development to Fill Finish

Sterile fill finish is often treated as a downstream step.

In reality, it is one of the most revealing stages of a program.

Decisions made in development directly impact fill-finish execution:

• Formulation choices affect stability and compatibility

• Container closure systems influence product behavior

• Filtration strategies impact recovery and performance

• Scheduling constraints shape timelines

If a CDMO treats fill finish as separate from development, gaps tend to appear later.

If they integrate fill-finish thinking early, those gaps are addressed before they become delays.

Strong partners connect development decisions to downstream execution from the beginning.

Why This Matters

The difference between a smooth program and a reactive one is rarely obvious at the proposal stage.

It shows up later, in how teams communicate, how decisions are made, and how challenges are handled.

From a business development perspective, this is where the real evaluation should happen.

Capabilities matter. Execution matters more.

Final Thoughts

Choosing a CDMO is not just about what they can do. It is about how they will work with you when things change.

If your team is evaluating partners, focus on:

• How they handle uncertainty

• How they involve expertise

• How they connect development through sterile fill finish

These are the factors that determine whether a program moves forward with momentum or becomes reactive.

My guide, How to Compare CDMO Quotes: 10 Factors Beyond Cost, helps biotech teams evaluate CDMOs beyond surface-level proposals so you can identify partners who are built for real execution.

Because the right partner is not just capable. They are prepared.

For more insights and personalized support in navigating the biotech-CDMO landscape, visit www.yourpharmagirl.com and follow Your Pharma Girl on LinkedIn. Whether you need strategic guidance, tailored business development solutions, or expert advice on building lasting partnerships, I am here to help you and your team succeed at every stage of development.